English | Español
Amanda Rupp | Jun 5, 2016

AbbVie to emphasize rheumatologic disease treatments for presentation
Amanda Rupp | Jun 5, 2016

AstraZeneca completes U.S. licensing agreement for Zurampic
Amanda Rupp | Jun 3, 2016

Purdue Pharma forms patent agreement with Acura, Egalet
Amanda Rupp | Jun 3, 2016

BioMarin withdraws Kyndrisa's marketing authorization for Europe
Amanda Rupp | Jun 2, 2016

Imbruvica gains approval for treating chronic lymphocytic leukemia
Amanda Rupp | Jun 1, 2016

NCHC applauds hospital readmissions policy changes
Amanda Rupp | Jun 1, 2016

CHMP gives positive opinion of Zepatier tablet
Amanda Rupp | Jun 1, 2016

First buprenorphine implant treatment for opioid dependence earns FDA approval

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’